Impact of the new reimbursement for secondary fracture prevention on inter-hospital variation in osteoporosis treatment for hip fracture patients: A nationwide analysis using DPC data
This study evaluated how the Secondary Fracture Prevention Continuity Management Fee (hereinafter, "the management fee"), established in Japan in April 2022, affected inter-hospital variation in osteoporosis medication prescription after hip fracture, and which hospital factors influenced its effectiveness. PURPOSE: This study evaluated how the Secondary Fracture Prevention Continuity Management Fee (hereinafter, "the management fee"), established in Japan in April 2022, affected inter-hospital variation in osteoporosis medication prescription after hip fracture, and which hospital factors influenced its effectiveness. METHODS: Using Diagnosis Procedure Combination data (April 2020-March 2024) from hospitals participating in the Quality Indicator/Improvement Project, we categorized hospitals as introduced or non-introduced. Inter-hospital variation was quantified using median odds ratios from a logistic mixed-effects model, and generalized estimating equations were used to examine hospital-level factors influencing the management fee's effectiveness. RESULTS: Among 168 hospitals (143 introduced, 25 non-introduced) and 76,111 patients, the prescription proportion in introduced hospitals increased from 30.9% to 71.8%, whereas it remained at approximately 20% in non-introduced hospitals. The median odds ratio in introduced hospitals increased significantly, from 2.66 (95% confidence interval 2.39-3.03) to 3.39 (2.96-4.00), indicating increased inter-hospital variation. The management fee's effectiveness was significantly lower in rural and private hospitals and those with low surgical volumes. CONCLUSION: The management fee functioned as an incentive for secondary fracture prevention, but its impact was uneven and increased inter-hospital disparities. Achieving equitable secondary fracture prevention may require a comprehensive approach that provides not only uniform financial incentives but also targeted support for hospitals with limited resources.
Authors
- Susumu Kunisawa (ORCID: https://orcid.org/0000-0002-3657-8686)
- Gaku Gondo (ORCID: https://orcid.org/0009-0008-2111-6340)
- Yuichi Imanaka (ORCID: https://orcid.org/0000-0003-4613-2159)
Institutions
- Kyoto University (JP)
- Center for Health Security, Graduate School of Medicine, Kyoto University (JP)
Publication Details
- Journal
- Osteoporosis International
- Published
- 2026-11-14
- DOI
- https://doi.org/10.1007/s00198-026-08308-8
- Primary Topic
- Bone health and osteoporosis research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Ministry of Health, Labour and Welfare
- Japan Society for the Promotion of Science